Combined use of biotine and thiamine for prevention and treatment of Hungtington Disease
Categoría
Drugs National Companies
Tipo de registro
Biotech Sanitaria
Nombre socio
Producto / Servicio
Combined use of biotine and thiamine for prevention and treatment of Hungtington Disease
Tipo
Biodrugs/ Drugs
Area terapéutica
Sistema nervioso central
Propiedades/Indicación
CSIC and the CIBERNED have determined that the combined administration of biotin and thiamine is capable of improving motor symptoms and reducing striatal atrophy associated with Huntington Disease (HD).
Fase de desarrollo
R&D
Localización de la Investigación
España